Istituzione del Sistema Dinamico di Acquisizione per la fornitura di Beni Farmaceutici
Original notice title
Istituzione del Sistema Dinamico di Acquisizione per la fornitura di Beni Farmaceutici. Finalizzato alla partecipazione di Appalti specifici per la stipula di Convenzioni/Accordi quadro. Il SDA potrà.
Opportunity Score
Why this score?
Opportunity
70 / 100
Complexity
60 / 100
Risk factors
DPS involves multiple subsequent tenders with varying requirements; companies must monitor all invitations.
The €15bn is an estimated maximum; actual spend may be lower or spread over many suppliers.
Restricted procedure — pre-qualification required
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Overview
Strong opportunityKey Facts
- EUR 15000M estimated value
- Dynamic Purchasing System (DPS)
- Supplies contract
- 1 lot
- Duration 132 MONTH
- Establishment of a Dynamic Purchasing System (DPS) for pharmaceutical products.
- Scope covers all pharmaceutical goods (CPV 33600000).
Show full summary
Istituzione del Sistema Dinamico di Acquisizione (DPS) for pharmaceutical products, managed by Intercent-ER (Emilia-Romagna regional agency). The DPS is valid for 132 months (until February 2028), with an estimated total value of €15 billion. It is a restricted procedure aimed at establishing a dynamic system for subsequent specific procurements (convenzioni/accordi quadro). Only one lot identified (LOT-0000). Submission deadline: 24/02/2028 18:00 (CET). All communication via the electronic platform. No procurement documents beyond the notice were analyzed.
Risks
DPS involves multiple subsequent tenders with varying requirements; companies must monitor all invitations.
The €15bn is an estimated maximum; actual spend may be lower or spread over many suppliers.
Restricted procedure — pre-qualification required
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
Technical
- All communications and clarifications must be done through the electronic system.
Administrative
- Participation requires prior admission to the DPS via the electronic platform.
- Admission requests can be submitted throughout the 96-month DPS validity period.
Requirements may be incomplete.
Buyer
Name
Intercent-ER — Agenzia regionale per lo sviluppo dei mercati telematici
Location
Bologna, ITA
Buyer profile
Identifier
0000246017
Lots (1)
LOT-0000
Istituzione del Sistema Dinamico di Acquisizione per la fornitura di Beni Farmaceutici
Single lot covering all pharmaceutical products (CPV 33600000). Detailed requirements for subsequent specific tenders will be provided in invitation letters. Duration: 132 months. DPS, not a framework agreement.
EUR 15B
Estimated value
Location
Duration
Category
Deadline
Award details
Value note
Show original TED data
Original lot title
Istituzione del Sistema Dinamico di Acquisizione per la fornitura di Beni Farmaceutici. Finalizzato alla partecipazione di Appalti specifici per la stipula di Convenzioni/Accordi quadro. Il SDA potrà.
Original TED description
Le prestazioni oggetto degli appalti specifici ed i requisiti di conformità, compatibilità, e le caratteristiche minime saranno dettagliati nelle singole lettere di invito e nella documentazione ad esse allegata.
Procurement Details
- Publication date
- 24 Feb 2025
- Notice type
- Contract notice — standard
- Languages
- Italian
Reference metadata
- Notice subtype
- 16
- Notice version
- 1
- Legal basis
- 32014L0024
Reference IDs
- Tender ID
- 125860-2025
- Source notice ID
- fdd02624-5b56-40f2-ae17-7b5c921eaa28
Documents (2)
Similar tenders
Denmark – Pharmaceutical products – Amgros 2027 1.1051.b
Poland – Pharmaceutical products – Dostawa produktów leczniczych do SPZZOZ w Wyszkowie
Romania – Pharmaceutical products – MEDICAMENTE - PRODUSE FARMACEUTICE
Denmark – Pharmaceutical products – Amgros 2027 1.1052.b
Latvia – Pharmaceutical products – Par reģistrēto un nereģistrēto medikamentu piegādi Elektronisko iepirkumu sistēmas dalībniekiem
Spain – Pharmaceutical products – Suministro de Aflibercept (DOE) Intravítreo 40 mg/ml
Opportunity Score
Why this score?
Opportunity
70 / 100
Complexity
60 / 100
Risk factors
DPS involves multiple subsequent tenders with varying requirements; companies must monitor all invitations.
The €15bn is an estimated maximum; actual spend may be lower or spread over many suppliers.
Restricted procedure — pre-qualification required
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications